Qi Tony Zhou Selected Research

Colistin (Coly-Mycin)

12/2021	An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin.
1/2021	Rescuing the Last-Line Polymyxins: Achievements and Challenges.
8/2020	Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells.
2/2020	Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
1/2020	Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance.
10/2019	Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model.
8/2018	Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa.
1/2018	Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
1/2018	Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.
1/2018	Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection Model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qi Tony Zhou Research Topics

Disease

23	Infections 02/2022 - 10/2013
12	Respiratory Tract Infections (Respiratory Tract Infection) 08/2020 - 10/2013
4	Cystic Fibrosis (Mucoviscidosis) 12/2021 - 01/2018
2	Communicable Diseases (Infectious Diseases) 03/2018 - 03/2015
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Reinfection 04/2021
1	Central Nervous System Infections (Central Nervous System Infection) 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Invasive Pulmonary Aspergillosis 11/2018
1	Critical Illness (Critically Ill) 01/2018
1	Burns 01/2018
1	Wound Infection (Wound Infections) 01/2018
1	Body Weight (Weight, Body) 11/2017
1	Cough 06/2017
1	Bronchial Spasm 06/2017
1	Lung Neoplasms (Lung Cancer) 06/2017
1	Neoplasms (Cancer) 06/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 02/2016
1	Gram-Negative Bacterial Infections 02/2016
1	Human Influenza (Influenza) 03/2015
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2015

Drug/Important Bio-Agent (IBA)

16	Colistin (Coly-Mycin)FDA Link 12/2021 - 10/2013
14	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2014
12	Polymyxins (Polymyxin)IBA 02/2022 - 02/2016
10	Pharmaceutical PreparationsIBA 03/2021 - 10/2013
6	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2021 - 01/2018
4	PowdersIBA 08/2020 - 08/2015
3	Peptides (Polypeptides)IBA 01/2020 - 03/2015
2	ivacaftorIBA 12/2021 - 01/2020
2	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2021 - 01/2018
2	AerosolsIBA 10/2020 - 08/2015
1	LipopeptidesIBA 01/2021
1	Sertraline (Zoloft)FDA LinkGeneric 12/2020
1	AcidsIBA 01/2020
1	Liposomes (Liposome)IBA 10/2019
1	Itraconazole (Sporanox)FDA LinkGeneric 11/2018
1	Protein Isoforms (Isoforms)IBA 03/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2018
1	Tamoxifen FDA LinkGeneric 01/2018
1	rifapentine (Priftin)FDA Link 08/2015
1	Small Interfering RNA (siRNA)IBA 03/2015
1	Antiviral Agents (Antivirals)IBA 03/2015

Therapy/Procedure

4	Therapeutics 04/2021 - 02/2016
3	Respiratory Therapy (Therapy, Respiratory) 03/2021 - 01/2018
3	Dry Powder Inhalers 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 06/2017 - 05/2015
1	Intravenous Administration 03/2021
1	Intravenous Injections 11/2018
1	Oral Administration 11/2018